Reuben Richards

Chief Exective Officer and Board of Directors

Former Chairman Emeritus, Chairman and CEO of Emcore (NASDAQ:EMKR). He was Senior Managing Director of Jesup & Lamont Capital Markets Inc., a Principal with Hauser, Richards & Co., and a Director of Prudential-Bache Capital Funding in its Investment Banking Division. He serves as a Director of Qusion Technologies, Inc. Mr. Richards also serves on the Board of Emcore Corp.'s Gelcorellc Joint Venture and is a Director of SA Telecommunications, Inc. Previously, he was a Member of Jesup & Lamont Merchant Partners, L.L.C.

Paul Cate

Chairman of the Board of Directors

Chief Executive Officer at Mark IV Capital, Inc. Over twenty-five years of executive experience in the real estate development and financial services fields, Mr. Cate has guided Mark IV Capital since 1998 setting the strategic direction and actively managing the execution of specific corporate goals.

Jack Berkel

Member, Board of Directors

Founder and Managing Principal, CA Capital Representatives and CA Capital CRE, primarily focused on developing and strengthening relationships across the real estate and technology markets. Jack has more than 25 years of experience in the areas of corporate strategy, executive management, organization development, human capital, compensation, and capital markets. His vast knowledge across all facets of an organization is an invaluable resource for the clients he serves. Earlier in his career, he held senior management positions with First Data Corporation, Gateway Corporation and Western Digital.

Gregory Weiss, Ph.D.

Co-founder and Member, Board of Directors

Professor of Chemistry, Molecular Biology, and Biochemistry at the University of California, Irvine. Dr. Weiss trained at Genentech, Harvard, and UC Berkeley before joining the faculty at UCI in 2000. His laboratory focuses on the interface between chemistry and biology, including the study of membrane proteins and bioelectronics.  Tenured in 2006, he is a full Professor and former Vice Chair.  His awards include Beckman Foundation Young Investigator, election to Fellow of the American Association for the Advancement of Science, and an Ig Nobel Prize in Chemistry for leading the team that “partially unboiled the egg.” He has co-authored 90 publications, co-invented >10 patents, and has presented 200 invited seminars. Dr. Weiss co-invented the PhageTech technology with Dr. Penner.

Richard Henson

Co-founder and Member, Board of Directors

Richard Henson is the Co-Founder of PhageTech, Inc., a development stage company based on novel immunodiagnostics technology recently developed by researchers at UC Irvine.  He has over 30 years of experience in medical device development and manufacturing.  He has also served on the boards of Halo Healthcare, a breast cancer diagnostic company; ResVeRx, Inc., a nutraceutical manufacturer and TWAComm, a telecommunications company.  He is also Co-Chairman of Octane Foundation and a board member of OCTANe as well as a former member of the Chancellors CEO Roundtable at UC Irvine.  He is an investor in several other medical technology firms.

Please reload

© 2019 PhageTech, Inc.     All rights reserved

Screen Shot 2017-07-13 at 2.07.46 PM.png